{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:27Z","timestamp":1707524247895},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,3]]},"DOI":"10.7759\/cureus.14818","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T15:20:07Z","timestamp":1620055207000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-Traumatic Intramuscular Hip Hematoma in a Cirrhotic Patient With Hepatocellular Carcinoma and Portal Vein Thrombosis Treated With Sorafenib and Low Molecular Weight Heparin"],"prefix":"10.7759","author":[{"given":"Christos","family":"Sotiropoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Thomopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061358","article-title":"Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review","volume":"20","author":"Kanda T","year":"2019","unstructured":"Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M. Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in chronic hepatitis B and C infections: a review. Int J Mol Sci. 2019, 20:1358. 10.3390\/ijms20061358","journal-title":"Int J Mol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v22.i32.7289","article-title":"Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016","volume":"22","author":"Chan SL","year":"2016","unstructured":"Chan SL, Chong CC, Chan AW, Poon DM, Chok KS. Management of hepatocellular carcinoma with portal vein tumor thrombosis: Review and update at 2016. World J Gastroenterol. 2016, 22:7289-300. 10.3748\/wjg.v22.i32.7289","journal-title":"World J Gastroenterol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000497161","article-title":"Sorafenib: experience and better management of side effects improve overall survival in hepatocellular carcinoma patients: a real-life retrospective analysis","volume":"8","author":"Raoul JL","year":"2019","unstructured":"Raoul JL, Adhoute X, Penaranda G, Perrier H, Castellani P, Oules V, Bourli\u00e8re M. Sorafenib: experience and better management of side effects improve overall survival in hepatocellular carcinoma patients: a real-life retrospective analysis. Liver Cancer. 2019, 8:457-6. 10.1159\/000497161","journal-title":"Liver Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.12.008","article-title":"Portal vein thrombosis","volume":"5","author":"Chawla YK","year":"2015","unstructured":"Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015, 5:22-40. 10.1016\/j.jceh.2014.12.008","journal-title":"J Clin Exp Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-120543","article-title":"Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents","volume":"111","author":"Crowther MA","year":"2008","unstructured":"Crowther MA, Warkentin TE. Bleeding risk and the management of bleeding complications in patients undergoing anticoagulant therapy: focus on new anticoagulant agents. Blood. 2008, 111:4871-9. 10.1182\/blood-2007-10-120543","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3347","article-title":"Anti-coagulation drug warfarin contributes to severe adverse outcomes in prolonged unsupervised use: a double-edged sword","volume":"10","author":"Ordookhanian C","year":"2018","unstructured":"Ordookhanian C, Kaloostian SW, Kaloostian PE. Anti-coagulation drug warfarin contributes to severe adverse outcomes in prolonged unsupervised use: a double-edged sword. Cureus. 2018, 10:e3347. 10.7759\/cureus.3347","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpra.2017.08.008","article-title":"Novel oral anticoagulant induced upper limb haematoma: a case report","volume":"16","author":"Kandamany N","year":"2018","unstructured":"Kandamany N, Tan H. Novel oral anticoagulant induced upper limb haematoma: a case report. JPRAS Open. 2018, 16:20-3. 10.1016\/j.jpra.2017.08.008","journal-title":"JPRAS Open"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/58035-non-traumatic-intramuscular-hip-hematoma-in-a-cirrhotic-patient-with-hepatocellular-carcinoma-and-portal-vein-thrombosis-treated-with-sorafenib-and-low-molecular-weight-heparin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:48Z","timestamp":1707507168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/58035-non-traumatic-intramuscular-hip-hematoma-in-a-cirrhotic-patient-with-hepatocellular-carcinoma-and-portal-vein-thrombosis-treated-with-sorafenib-and-low-molecular-weight-heparin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.14818","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,3]]}}}